Scholarlink

<p>Pressure-modifying microcatheters, including balloon and microvalve systems, alter embolic delivery during transarterial therapies by modifying downstream arterial pressure and flow dynamics. Tumor vasculature is characterized by irregular architecture, elevated interstitial pressure, and impaired autoregulation, which limit homogeneous embolic penetration and reduce tumor-to-normal liver ratio (TNR). Mechanical mechanisms such as anti-reflux protection, catheter tip centering, and improved embolisate homogenization enhance distal particle distribution. Physiologic effects include decreased downstream perfusion pressure, preferential constriction of normal hepatic arteries, intrahepatic flow redistribution, and transient pressure augmentation during infusion, facilitating deeper tumor penetration. Preclinical, computational, and clinical studies demonstrate improved embolic efficiency, tumor uptake, absorbed dose, and objective response rates in selected settings. Understanding these complementary mechanical and physiologic mechanisms may optimize patient selection and procedural strategy.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pressure modification during hepatic tumor embolization: principles, mechanism of action, and current evidence

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月19日

查看全文
  • Zachary T. Berman,
  • Venkatesh P. Krishnasamy

摘要

Pressure-modifying microcatheters, including balloon and microvalve systems, alter embolic delivery during transarterial therapies by modifying downstream arterial pressure and flow dynamics. Tumor vasculature is characterized by irregular architecture, elevated interstitial pressure, and impaired autoregulation, which limit homogeneous embolic penetration and reduce tumor-to-normal liver ratio (TNR). Mechanical mechanisms such as anti-reflux protection, catheter tip centering, and improved embolisate homogenization enhance distal particle distribution. Physiologic effects include decreased downstream perfusion pressure, preferential constriction of normal hepatic arteries, intrahepatic flow redistribution, and transient pressure augmentation during infusion, facilitating deeper tumor penetration. Preclinical, computational, and clinical studies demonstrate improved embolic efficiency, tumor uptake, absorbed dose, and objective response rates in selected settings. Understanding these complementary mechanical and physiologic mechanisms may optimize patient selection and procedural strategy.

Graphical Abstract